In prostate cancer, Owens and colleagues demonstrated a unique mechanism by which PRMT5 and cofactor pICln coordinate H4R3me2s-mediated transcriptional activation at DDR promoters in response to irradiation (14). Here, PRMT5 is linked to prostate cancer.